Cell-mediated and humoral immune responses in children infected with human immunodeficiency virus during the first four years of life
- PMID: 1538282
- DOI: 10.1016/s0022-3476(05)80899-6
Cell-mediated and humoral immune responses in children infected with human immunodeficiency virus during the first four years of life
Abstract
Objectives: To determine whether cell-mediated and humoral immune responses to recall antigens develop in children infected with the human immunodeficiency virus (HIV) and, if so, whether these responses are retained.
Methods: Children infected with HIV and uninfected children born to mothers infected with HIV were compared with respect to lymphoproliferative responses to recall antigens and protective levels of antibody to bacterial toxoids during the first 4 years of life.
Results: Children infected with HIV who were enrolled in a prospective study of the natural history of the infection were relatively normal (1) in their lymphoproliferative responses to diphtheria toxoid, tetanus toxoid, and Candida, and (2) in their ability to make protective diphtheria and tetanus antitoxins during the first 2 years of life. During the next 2 years, attrition was noted in both lymphoproliferative and humoral responses. Attrition in response was not necessarily correlated with declining numbers of helper T cells.
Conclusions: These results suggest that both cellular and humoral immune responses develop early in life in most children infected with HIV, while they remain relatively well both clinically and immunologically. Previously reported severe immune deficits in these children were probably attributable to advanced clinical disease when they were first studied.
Similar articles
-
Cellular and humoral immune responses to a tetanus toxoid booster in perinatally HIV-1-infected children and adolescents receiving highly active antiretroviral therapy (HAART).Eur J Pediatr. 2007 Jan;166(1):51-6. doi: 10.1007/s00431-006-0184-2. Epub 2006 Jul 26. Eur J Pediatr. 2007. PMID: 16868780
-
Correlation of clinical parameters and immunological function with human immunodeficiency virus plasma viremia in children.Viral Immunol. 1999;12(2):139-48. doi: 10.1089/vim.1999.12.139. Viral Immunol. 1999. PMID: 10413360
-
Correlation of in vitro T-cell and B-cell function with responses to childhood vaccines in children with human immunodeficiency virus infection.Viral Immunol. 1997;10(4):197-206. doi: 10.1089/vim.1997.10.197. Viral Immunol. 1997. PMID: 9473150
-
Delayed-type hypersensitivity skin testing in human immunodeficiency virus-infected pediatric patients.J Pediatr. 1996 Aug;129(2):245-50. doi: 10.1016/s0022-3476(96)70249-4. J Pediatr. 1996. PMID: 8765622
-
The Effect of Human Immunodeficiency Virus and Cytomegalovirus Infection on Infant Responses to Vaccines: A Review.Front Immunol. 2018 Mar 2;9:328. doi: 10.3389/fimmu.2018.00328. eCollection 2018. Front Immunol. 2018. PMID: 29552009 Free PMC article. Review.
Cited by
-
Safety and immunogenicity of early measles vaccination in children born to HIV-infected mothers in the United States: results of Pediatric AIDS Clinical Trials Group (PACTG) protocol 225.J Infect Dis. 2011 Jul;204 Suppl 1(Suppl 1):S179-89. doi: 10.1093/infdis/jir089. J Infect Dis. 2011. PMID: 21666159 Free PMC article. Clinical Trial.
-
Contribution of the HIV-1 Envelope Glycoprotein to AIDS Pathogenesis and Clinical Progression.Biomedicines. 2022 Sep 2;10(9):2172. doi: 10.3390/biomedicines10092172. Biomedicines. 2022. PMID: 36140273 Free PMC article. Review.
-
Vaccination in patients with HIV infection.Curr Infect Dis Rep. 2006 Mar;8(2):151-61. doi: 10.1007/s11908-006-0011-y. Curr Infect Dis Rep. 2006. PMID: 16524552
-
Vaccination in HIV-infected Patients.Curr Infect Dis Rep. 2000 Jun;2(3):245-256. doi: 10.1007/s11908-000-0042-8. Curr Infect Dis Rep. 2000. PMID: 11095863
-
Highly active antiretroviral therapy restores in vitro mitogen and antigen-specific T-lymphocyte responses in HIV-1 perinatally infected children despite virological failure.Clin Exp Immunol. 2002 May;128(2):365-71. doi: 10.1046/j.1365-2249.2002.01814.x. Clin Exp Immunol. 2002. PMID: 11985529 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical